Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643) |
---|
02/25/2009 | EP1716113B1 Ep2- receptor agonists |
02/25/2009 | CN101374599A Alkaline earth-based alkoxylation catalysts |
02/24/2009 | US7495020 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
02/24/2009 | US7494684 Such as sodium/lithium/potassium lactate for use in premixes/concentrates/flavorings for foodstuffs |
02/24/2009 | CA2212507C Cobaltous oxide containing metallic cobalt, methods for producing the same and use thereof |
02/19/2009 | WO2009021987A1 Process for the preparation of esters of 4-fluorosubstituted 3-oxo-alcanoic acids |
02/19/2009 | WO2008152333A3 Novel derivatives of 3-phenyl propanoic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions |
02/19/2009 | US20090048257 Compounds that modulate ppar activity, their preparation and use |
02/19/2009 | US20090047687 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation |
02/19/2009 | DE102007036998A1 Verfahren zur Herstellung von amorphen metallorganischen Makromolekülen, mit diesem Verfahren erhaltenes Material und seine Verwendung A process for the preparation of amorphous metal organic macromolecules, obtained by this process material and its use |
02/18/2009 | EP2025663A1 Novel carboxylic acid compound, use thereof, and process for producing the same |
02/18/2009 | EP2024316A1 Crystalline leukotriene b4 |
02/18/2009 | CN100462354C Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
02/18/2009 | CN100462350C Process for directly producing calcium lactate from crust and lactic acid |
02/17/2009 | US7491836 Polyoxyalkylene glycols or monoalkylated polyoxyalkylene glycols esterified with O-acylated, O-alkylated or O-alkenylated hydroxy fatty acids; high bioavailability |
02/17/2009 | US7491748 e.g. (1) 3-(2-((naphthalen-1-ylmethyl)carbamoyl)-4-(2-methylphenoxymethyl)phenyl)propanoic acid; prostaglandin (PGE2) receptor ligand; analgesic, anticarcinogenic agent, antiallergen; neurodegenerative diseases |
02/12/2009 | WO2009018959A1 Salts of tramadol and naproxen and their crystal forms in the treatment of pain |
02/12/2009 | US20090043109 Asymmetric one- and two-photon fluorophores for simultaneous detection of multiple analytes using a common excitation source |
02/12/2009 | US20090042832 Novel salts of boswellic acids and selectively enriched boswellic acids and processes for the same |
02/11/2009 | EP2022778A1 A crystalline form of (R,R)-tramadol-(S)-naproxene salt |
02/11/2009 | EP2022775A2 Trihydroxy polyunsaturated eicosanoids |
02/11/2009 | EP2021314A1 Substituted biphenyl carboxylic acids and derivatives thereof |
02/11/2009 | EP2021313A1 Biomarkers for diagnosing multiple sclerosis, and methods thereof |
02/11/2009 | CN101362686A 乙醛酸生产技术 Glyoxylic acid production technology |
02/11/2009 | CN101361727A Apoptosis inhibitor |
02/10/2009 | US7488759 Malic acid addition salts of terbinafine |
02/10/2009 | CA2294098C Novel thyroid receptor ligands and method |
02/05/2009 | US20090036691 Analogs of dicodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof |
02/05/2009 | US20090036635 Promoter for polycondensation reaction |
02/05/2009 | US20090036530 Crystalline acid of lipoxin A4 analogs and method of making |
02/05/2009 | US20090036525 Non-Natural Amino Acid Derivatives |
02/05/2009 | DE10348674B4 Racemisierung von optisch aktiven 2-substituierten Phenylglycinestern Racemization of optically active 2-substituted Phenylglycinestern |
02/05/2009 | DE102008033165A1 Verfahren zum Herstellen eines optisch aktiven ß-Hydroxycarbonsäurederivats A method for producing an optically active beta-hydroxycarboxylic acid derivative |
02/04/2009 | EP1565422B1 Vitamin d receptor modulators |
01/29/2009 | WO2009014471A2 Method for producing mechanically activated amorphous and amorphocrystalline compounds of gluconic acid calcium salt |
01/29/2009 | WO2009014235A1 Hydroxy acid amine salt, method for producing the same, and rubber composition containing the same |
01/29/2009 | WO2009014167A1 Novel compound, method for producing the same and method for producing fluoropolymer |
01/29/2009 | WO2009014105A1 Novel carboxylic acid and antidepressant composition containing the same as active ingredient |
01/29/2009 | US20090030213 Stabalized Vegetable Oils And Methods Of Making Same |
01/29/2009 | US20090029947 Sphingosine-1-phosphate receptor agonist and antagonist compounds |
01/28/2009 | EP1412043B1 Azeotropic distillation of cyclic esters of hydroxy organic acids |
01/27/2009 | US7482484 Carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia |
01/22/2009 | WO2008110339A3 Polymorphs of rivastigmine hydrogentartrate |
01/22/2009 | US20090023926 Biopolymer ionization; liquid chromatography |
01/21/2009 | EP2016039A1 Terphenyl derivatives for treatment of alzheimer' s disease |
01/21/2009 | CN101348474A Method for preparing salvianolic acid B and tanshinol from Salvia miltiorrhiza stem |
01/21/2009 | CN101348431A Method for producing low lead light density granular calcium citrate |
01/21/2009 | CN101348430A Method for preparing acetylpropionic acid by solid superacid catalysis of stalk |
01/21/2009 | CN101347504A Effective component of salvia root and preparation thereof and use |
01/20/2009 | CA2512630C Novel process for preparing a 5-hydroxy-3-oxo-hexanoic acid derivative |
01/20/2009 | CA2364944C C16 unsaturated fp-selective prostaglandins analogs |
01/20/2009 | CA2174061C 7-substituted quinone methides as inhibitors for unsaturated monomers |
01/15/2009 | WO2009007193A1 Method for the production of ketoacids and their derivatives |
01/15/2009 | WO2008062460A3 Crystalline forms of pregabalin |
01/15/2009 | US20090018342 New epothiolone derivatives, process for their production, and their pharmaceutical use |
01/15/2009 | US20090018058 Vitamin D Receptor Modulators |
01/15/2009 | DE102007031917A1 Verfahren zur Herstellung von Ketosäuren und deren Derivaten Process for the preparation of keto acids and their derivatives |
01/15/2009 | CA2692758A1 A crystalline synthetic intermediate for preparation of a dpp-iv inhibitor and method of purification thereof |
01/14/2009 | EP2012770A2 Trivalent chromium compounds, compositions and methods of use |
01/14/2009 | EP1575532A4 Mixed esters of dicarboxylic acids for use as pigment dispersants |
01/14/2009 | EP1477472B1 Substituted phenylalkanoic acid derivative and use thereof |
01/14/2009 | CN101343221A Method for fine purification of 10-hydroxyl radical n-decanoic acid with macroporous resin |
01/14/2009 | CN100450991C Process for preparing peach leaf mandelic acid extract |
01/13/2009 | US7476742 treatment of disease such as diabetes, obesity, hyperlipidemia, and atherosclerotic disease; e.g. ethyl (5-methoxy-2,3-dihydro-1H-inden-1-ylidene)ethanoate |
01/08/2009 | WO2008040650A3 Photocurable compositions comprising a photoinitiator of the phenylglyoxylate type |
01/08/2009 | WO2007131012A9 12-aryl or heteroaryl prostaglandin analogs |
01/08/2009 | US20090012171 Novel Compounds, Their Preparation and Use |
01/08/2009 | US20090012093 Receptor Function Regulator |
01/07/2009 | CN101341113A Process for preparing octenoic acid derivatives |
01/07/2009 | CN101337882A Method for purifying rupestonic acid and chrysosplenetin B by high speed reversed flow chromatography |
01/07/2009 | CN101337881A Method for preparing trans-ferulaic acid, p-cumaric acid and pentosan |
01/07/2009 | CN100448836C Method for preparing key intermediate of medication for anti AIDS |
01/07/2009 | CN100448834C A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide |
01/07/2009 | CN100448818C Method for extracting and method for purifying effective substance |
01/06/2009 | US7473795 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors |
01/06/2009 | US7473704 Cyclohexyl prostaglandin analogs as EP4-receptor agonists |
12/31/2008 | WO2009001046A2 [11c]methoxy-radiolabelled 2,3',4,5'-tetramethylstilbene (tms) and its preparation and use |
12/31/2008 | WO2008135482A3 Ionic liquids comprising polyethercarboxylates as anions, production and use thereof |
12/31/2008 | EP2007705A1 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use |
12/31/2008 | EP2007702A2 Conjugated lipid derivatives |
12/30/2008 | US7470813 Method for the production of pyruvic acid |
12/30/2008 | US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
12/25/2008 | US20080318787 Use of S-Abscisic Acid for Improving Fruit Set and Producing Parthenocarpic Fruits and as a Growth Inhibitor |
12/24/2008 | WO2008157537A2 Compositions and methods of use for treating or preventing lipid related disorders |
12/24/2008 | WO2008156095A1 Method for producing optically active trans-2-aminocyclohexanol and intermediate of optically active trans-2-aminocyclohexanol |
12/24/2008 | EP1907346B1 Method for extracting lactic acid from aqueous suspensions |
12/24/2008 | EP1627866B1 Carboxylic acid compound and medicine containing the same |
12/24/2008 | CN100445293C Supermolecular carboplatinum derivatives, their preparation method, and pharmaceutical composition containing them as active ingredient and applications of the composition |
12/24/2008 | CA2684476A1 Method for producing optically active trans-2-aminocyclohexanol and intermediate of optically active trans-2-aminocyclohexanol |
12/23/2008 | US7468457 Skin disorders; antiproliferative agents; metabolism disorders; obesity; antihistamines; antidiabetic agents |
12/23/2008 | CA2386627C Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
12/18/2008 | WO2008152333A2 Novel derivatives of 3-phenyl propanoic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions |
12/18/2008 | US20080312462 Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives |
12/18/2008 | US20080312457 Process |
12/18/2008 | US20080312322 Organic Compounds |
12/18/2008 | US20080312321 Therapeutic substituted cyclopentanes |
12/18/2008 | US20080312308 Substituted acetic acid derivatives |
12/18/2008 | US20080312186 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
12/18/2008 | US20080308402 Purification of aqueous solutions of organic acids |
12/18/2008 | CA2688239A1 Novel derivatives of 3-phenyl propanoic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions |